| Texto completo | |
| Autor(es): |
de Lima-Vasconcellos, Theo Henrique
;
Bovi dos Santos, Gabrieli
;
Movio, Marilia Ines
;
Donnici, Giovanna Klemenc
;
Badin, Gabriela Maria
;
de Araujo, Daniele Ribeiro
;
Kihara, Alexandre Hiroaki
Número total de Autores: 7
|
| Tipo de documento: | Artigo Científico |
| Fonte: | NEURAL REGENERATION RESEARCH; v. 21, n. 3, p. 15-pg., 2026-03-01. |
| Resumo | |
The intricate landscape of neurodegenerative diseases complicates the search for effective therapeutic approaches. Photoreceptor degeneration, the common endpoint in various retinal diseases, including retinitis pigmentosa and age-related macular degeneration, leads to vision loss or blindness. While primary cell death is driven by genetic mutations, oxidative stress, and neuroinflammation, additional mechanisms contribute to disease progression. In retinitis pigmentosa, a multitude of genetic alterations can trigger the degeneration of photoreceptors, while other retinopathies, such as age-related macular degeneration, are initiated by combinations of environmental factors, such as diet, smoking, and hypertension, with genetic predispositions. Nutraceutical therapies, which blend the principles of nutrition and pharmaceuticals, aim to harness the health benefits of bioactive compounds for therapeutic applications. These compounds generally possess multi-target effects. Polyphenols and flavonoids, secondary plant metabolites abundant in plant-based foods, are known for their antioxidant, neuroprotective, and anti-inflammatory properties. This review focuses on the potential of polyphenols and flavonoids as nutraceuticals to treat neurodegenerative diseases such as retinitis pigmentosa. Furthermore, the importance of developing reliable delivery methods to enhance the bioavailability and therapeutic efficacy of these compounds will be discussed. By combining nutraceuticals with other emerging therapies, such as genetic and cell-based treatments, it is possible to offer a more comprehensive approach to treating retinal degenerative diseases. These advancements could lead to a viable and accessible option, improving the quality of life for patients with retinal diseases. (AU) | |
| Processo FAPESP: | 24/00828-3 - Utilização de flavonóides para o tratamento da retinose pigmentar autossômica recessiva: uma abordagem nutracêutica |
| Beneficiário: | Théo Henrique de Lima Vasconcellos |
| Modalidade de apoio: | Bolsas no Brasil - Doutorado |
| Processo FAPESP: | 24/10858-7 - Terapia nutracêutica: efeito de rutina na gliose reativa em retinose pigmentar autossômica recessiva |
| Beneficiário: | Gabriela Maria Badin Correa |
| Modalidade de apoio: | Bolsas no Brasil - Iniciação Científica |
| Processo FAPESP: | 20/11667-0 - Alterações celulares e eletrofisiológicas no hipocampo causadas por processos neurodegenerativos relacionados com anóxia neonatal e epilepsia do lobo temporal |
| Beneficiário: | Alexandre Hiroaki Kihara |
| Modalidade de apoio: | Auxílio à Pesquisa - Regular |
| Processo FAPESP: | 21/11969-9 - Papel de IP3R1 na neuroinflamação desencadeada pela retinose pigmentar |
| Beneficiário: | Théo Henrique de Lima Vasconcellos |
| Modalidade de apoio: | Bolsas no Brasil - Mestrado |
| Processo FAPESP: | 21/14227-3 - Estabelecimento de um modelo 3d in vitro de retinose pigmentar |
| Beneficiário: | Gabrieli Bovi dos Santos |
| Modalidade de apoio: | Bolsas no Brasil - Mestrado |